Surveillance Research Program
6116 Executive Blvd.
Suite 504
Bethesda, MD
USA 20892
Email: lewisde@mail.nih.gov
Disclosure statement:
Qualified on the content I am responsible for because: I have a Ph.D. in epidemiology (Johns Hopkins) and an M.P.H. in infectious disease epidemiology (Yale). Previous work experience includes 10 years at NCI working on a variety of cancer issues; 5 years at EPA working on water issues for arsenic and disinfection by-products that included presentations at international meetings and workgroups; 2 years at USDA conducting foodborne outbreak investigations in USDA inspected products; 2 years as a clinical microbiologist in a hospital setting. For the past 5 years, I have also been a program director of grants for cancer surveillance and geo-spatial research. I have a list of publications in these areas:
PUBLICATIONS:
1. Riedel DA, Evans AS, Saxinger C, Blattner WA. A Historical Study of Human T Lymphotropic Virus Type I Transmission in Barbados. Journal of Infectious Diseases 1989;159:603-609.
2. Blattner WA, Saxinger C, Riedel D, Hull B, Taylor G, Cleghorn F, Gallo R, Blumberg B, Bartholomew C. A Study of HTLV-I and Its Associated Risk Factors in Trinidad and Tobago. J Acquired Immune Def Syndromes 1990;3:1102-1108.
3. Bush TL, Riedel DA. Screening for Total Cholesterol. Do the National Cholesterol Education Program’s Recommendations Detect Individuals at High Risk of Coronary Heart Disease? Circulation 1991;83:1287-1293.
4. Riedel DA. Re: Human T-Lymphotropic Virus (HTLV-I) Seroprevalence in Jamaica. I. Demographic Determinants. II. Geographic and Ecologic Determinants. (Letter to the editor). Am J Epidemiol 1992;135:591.
5. Zahm SH, Pottern LM, Lewis DR, Ward MH, White DW. Inclusion of Women and Minorities in Occupational Cancer Epidemiologic Research. J Occ Med 1994;36:842-847.
6. Lewis DR, Pottern LM, Brown LM, Silverman DT, Hayes RB, Schoenberg JB, Greenberg RS, Swanson GM, Schwartz AG, Liff JM, Hoover RN. Multiple Myeloma Among Blacks and Whites in the United States: The Role of Chronic Antigenic Stimulation. Cancer Causes and Control 1994;5:529-539. (Published Doctoral Dissertation).
7. Subar AF, Thompson FE, Smith AF, Jobe JB, Ziegler RG, Potischman N, Schatzkin A, Hartman A, Swanson C, Kruse L, Hayes R, Lewis DR, Harlan LC. Improving Food Frequency Questionnaires: A Qualitative Approach Using Cognitive Interviewing. J Am Dietetic Assoc 1995;95:781-788.
8. Lewis DR, Southwick JW, Scanlan LP, Rench J, Calderon RL. The Feasibility of Epidemiologic Studies of Waterborne Arsenic: A Mortality Study in Millard County, Utah. Journal of Environmental Health 1998; 60 (9): 14-19.
9. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL. Drinking Water Arsenic in Utah: A Cohort Mortality Study. Environmental Health Perspectives 1999; 107 (5): 359-365.
10. Lewis DR, Calderon RL, Southwick JW, Ouellet-Hellstrom R, Rench J. Re: Drinking Water Arsenic in Utah: A Cohort Mortality Study (response to letter to the editor). Environmental Health Perspectives 1999; 107 (11): A4-A5.
11. St. George DMM, Wing SB, Lewis DR. Geographic and Temporal Patterns of Toxic Chemical Releases to the Environment from Manufacturing Facilities in North Carolina. North Carolina Medical Journal 1999; 61(1):396-400.
12. Ries LAG, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program. The Oncologist 2003; 8(6):541-552.
13. Stewart SL, Wike, JM, Ikuko K, Lewis DR, Michaud F. A Population-based Study of Colorectal Cancer Histology in the United States, 1998-2001. Cancer 2006; 107(5 Suppl): 1128-1141.
14. Pickle LW, Szczur M, Lewis DR, Stinchcomb DG. The Crossroads of GIS and Health Information: A Workshop on Developing a Research Agenda to Improve Cancer Control. Int J Health Geogr 2006; 5(1):51. Available from http://www.ij healthgeographics.com/content/5/1/51.
15. Percy-Laurry AL, Johnson CH, Reichman ME, Adamo M, Lewis DR, Peace S. Revising the Multiple Primary and Histology Coding Rules. Journal of Registry Management 2007; 34(3): 81-86.
16. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site, 2008.
17. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
18. Lewis DR, Clegg LX, Johnson NJ. Lung Disease Mortality in the United States: the National Longitudinal Mortality Study. Int J Tuberc Lung Dis 2009; 13(8): 1008-1014.
BOOK CHAPTERS and MONOGRAPHS:
1. Riedel DA, Pottern LM, Blattner WA. Epidemiology of Multiple Myeloma. In: Neoplastic Diseases of the Blood. Wiernik PH, Canellos GP, Kyle RA, Schiffer CA, eds. 2nd edition. New York: Churchill Livingstone, Inc., April 1991.
2. Riedel DA. Epidemiologic Studies of Multiple Myeloma: Occupation and Radiation Effects. In: Epidemiology & Biology of Multiple Myeloma. Obrams GI, Potter M, eds. Berlin Heidelberg: Springer-Verlag, June 1991.
3. Riedel DA, Pottern LM. The Epidemiology of Multiple Myeloma. In: Hematology/Oncology Clinics of North America-Multiple Myeloma. Barlogie B, ed. Philadelphia: W.B. Saunders Co., April 1992, Vol. 6, pp. 225-247.
4. Lewis DR. Drinking Water Arsenic: The Millard County, Utah Mortality Study. In: Proceedings of the Third International Conference on Arsenic Exposure and Health Effects. Chappell, W.R., Abernathy, C.O., Calderon, R.L., (Eds.). Elsevier Science, 1999, pp. 133-140. ISBN 0 08 043 648 X.
5. Lewis DR, Ries LAG. Chapter 10: Cancers of the Bone and Joint. In: SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, (Eds.). National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.